RAF1 and hypertrophic cardiomyopathy: Studies on 3D bioartificial cardiac tissues reveal the impacts of hypertrophic cardiomyopathy-associated RAF1 mutations on sarcomere structure, contractile behavior, Ca2+ handling, and intracellular signaling.